BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27752823)

  • 21. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia.
    Douer D; Preston-Martin S; Chang E; Nichols PW; Watkins KJ; Levine AM
    Blood; 1996 Jan; 87(1):308-13. PubMed ID: 8547657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haematological & molecular profile of acute myelogenous leukaemia in India.
    Sazawal S; Kumar B; Hasan SK; Dutta P; Kumar R; Chaubey R; Mir R; Saxena R
    Indian J Med Res; 2009 Mar; 129(3):256-61. PubMed ID: 19491417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global characteristics of childhood acute promyelocytic leukemia.
    Zhang L; Samad A; Pombo-de-Oliveira MS; Scelo G; Smith MT; Feusner J; Wiemels JL; Metayer C
    Blood Rev; 2015 Mar; 29(2):101-25. PubMed ID: 25445717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics, outcome and early induction deaths in patients with acute promyelocytic leukaemia: a five-year experience at a tertiary care centre.
    Karim F; Shaikh U; Adil SN; Khurshid M
    Singapore Med J; 2014 Aug; 55(8):443-7. PubMed ID: 25189308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies.
    Sanz MA; Montesinos P; Kim HT; Ruiz-Argüelles GJ; Undurraga MS; Uriarte MR; Martínez L; Jacomo RH; Gutiérrez-Aguirre H; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Vellenga E; Holowiecka A; González-Huerta AJ; Fernández P; De la Serna J; Brunet S; De Lisa E; González-Campos J; Ribera JM; Krsnik I; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Rego EM;
    Ann Hematol; 2015 Aug; 94(8):1347-56. PubMed ID: 25975975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of acute myeloid leukemia without HLA-DR expression.
    Moon H; Lee S; Huh J; Chung WS
    Korean J Lab Med; 2007 Oct; 27(5):313-7. PubMed ID: 18094594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia.
    Estey E; Thall P; Kantarjian H; Pierce S; Kornblau S; Keating M
    Leukemia; 1997 Oct; 11(10):1661-4. PubMed ID: 9324286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemiology of acute promyelocytic leukaemia.
    Douer D
    Best Pract Res Clin Haematol; 2003 Sep; 16(3):357-67. PubMed ID: 12935956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trials.
    Micol JB; Raffoux E; Boissel N; Lengliné E; Canet E; Daniel MT; Labarthe Ad; Maarek O; Cassinat B; Adès L; Baruchel A; Degos L; Azoulay E; Dombret H
    Eur J Cancer; 2014 Apr; 50(6):1159-68. PubMed ID: 24440088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain infarction and blasts with bilobed nuclei in a patient with monocytic acute myeloid leukemia mimicking acute promyelocytic leukemia.
    Elghazaly AA; Ibrahim MH; AlGwaiz LA
    Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):116-7. PubMed ID: 26802620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy-related acute myeloid leukemia (t-AML) with poor-risk cytogenetics in two patients with persistent molecular complete remission of acute promyelocytic leukemia.
    Ojeda-Uribe M; Schneider A; Luquet I; Berceanu A; Cornillet-Lefebvre P; Jeandidier E; Lioure B; Ades L; Mauvieux L; Himberlin C
    Eur J Haematol; 2012 Sep; 89(3):267-72. PubMed ID: 22591288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute myeloid leukaemia in Western Australia 1991-2005: a retrospective population-based study of 898 patients regarding epidemiology, cytogenetics, treatment and outcome.
    Gangatharan SA; Grove CS; P'ng S; O'Reilly J; Joske D; Leahy MF; Threlfall T; Wright MP
    Intern Med J; 2013 Aug; 43(8):903-11. PubMed ID: 23611681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A convolutional neural network-based, quantitative complete blood count scattergram-mapping framework promptly screens acute promyelocytic leukemia with high sensitivity.
    Liao H; Xu Y; Meng Q; Mao Z; Qiao Y; Liu Y; Zheng Q
    Cancer; 2023 Oct; 129(19):2986-2998. PubMed ID: 37254628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Could Acute Myeloid Leukemia Have Presented Even Worse? "Uncommon Cause of Concurrently Multivessel Thrombosis".
    Hazir KE; Simsek EC; Baldan E; Uzun HG; Bulbul H; Yarci B; Ozcan EB
    Arq Bras Cardiol; 2023 Jul; 120(8):20220808. PubMed ID: 37586004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.
    Paietta E; Andersen J; Gallagher R; Bennett J; Yunis J; Cassileth P; Rowe J; Wiernik PH
    Leukemia; 1994 Jul; 8(7):1108-12. PubMed ID: 8035602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia.
    Lazarevic V; Hörstedt AS; Johansson B; Antunovic P; Billström R; Derolf Å; Lehmann S; Möllgård L; Peterson S; Stockelberg D; Uggla B; Vennström L; Wahlin A; Höglund M; Juliusson G
    Eur J Haematol; 2015 May; 94(5):419-23. PubMed ID: 25200361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adding ascorbic acid to arsenic trioxide produces limited benefit in patients with acute myeloid leukemia excluding acute promyelocytic leukemia.
    Aldoss I; Mark L; Vrona J; Ramezani L; Weitz I; Mohrbacher AM; Douer D
    Ann Hematol; 2014 Nov; 93(11):1839-43. PubMed ID: 24906216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunophenotypic features in 143 cases of acute promyelocytic leukemia].
    Sun HM; Qian SX; Wu YJ; Qiao C; Hong M; Fan L; Yang H; Zhang JF; Zhang SJ; Wu HX; Qiu HX; Lu H; Xu W; Sheng RL; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):176-9. PubMed ID: 19236773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.